0001127602-17-025060.txt : 20170804 0001127602-17-025060.hdr.sgml : 20170804 20170804175100 ACCESSION NUMBER: 0001127602-17-025060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170804 FILED AS OF DATE: 20170804 DATE AS OF CHANGE: 20170804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graham Jonathan P CENTRAL INDEX KEY: 0001365306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 171009644 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE, NW STREET 2: 12TH FLOOR CITY: WASHINGTON STATE: DC ZIP: 20006 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-08-04 0000318154 AMGEN INC AMGN 0001365306 Graham Jonathan P ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP, Gen. Counsel & Secy. Common Stock 2017-08-04 4 F 0 6747 174.18 D 44165 D These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 24,600 RSUs which vest in two equal installments of 12,300 on 8/4/2018 and 8/4/2019; 2,942 RSUs which vest in three installments of 970 on 5/3/2018, 971 on 5/3/2019 and 1,001 on 5/3/2020; and 3,075 RSUs which vest in installments of 1,014 on 5/1/2019, 1,015 on 5/1/2020 and 1,046 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 1,351 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. /s/ Jonathan P. Graham 2017-08-04